The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,430,948 in first-year total cost, median $1,430,948.
Most frequent study sections
- Special Emphasis Panel[ZDA1 JXR-D (12)]1
Most frequent institutions
- MAYO CLINIC ROCHESTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Definitive Preclinical Studies of Hydrolase Gene Transfer to Treat Cocaine Abuse1UG3DA042492-01 | BRIMIJOIN, WILLIAM STEPHEN | MAYO CLINIC ROCHESTER, MN | $1,430,948 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.